CAT and cancer: The catalytic activity enables NanoICD/CAT to decompose H2O2 (Fig. 5C) and generate O2 effectively (Fig. 5D), thus providing the potential to alleviate tumor hypoxia and remodel immunosuppressive TME to enhance cancer immunotherapy.